Skip to main content
. Author manuscript; available in PMC: 2013 Jan 30.
Published in final edited form as: J Autoimmun. 2012 Jun 23;39(3):216–221. doi: 10.1016/j.jaut.2012.05.022

Figure 5.

Figure 5

IgM inhibition of the maturation of bone marrow-derived DC. Myeloid DC were pretreated with IgM (20 µg/ml) for an hour, then stimulated with LPS (1µg/ml) for 48 hours. Flow cytometry ananlysis was performed to observe the expression of MHC II, CD80 and CD86 in immature (left) and mature (Right) myeloid DC treated with (Blue) or without (Red) IgM (* p<0.05).